‘The Ripple’ Podcast To Feature Ben&Ben, Moira, SB19, And More

This Monday, The Ripple podcast welcomes a lineup of music icons including Moira Dela Torre and SB19.

‘My Love Will Make You Disappear’ Makes PHP40 Million In Four Days

In its opening weekend, "My Love Will Make You Disappear" takes the box office by storm, earning PHP40 million.

DBM: Infra Spending Reaches PHP1.545 Trillion In 2024

Ang imprastraktura ng bansa ay umabot sa PHP1.545 trilyon sa 2024, nagpakita ng pagtaas na 8.9 porsyento mula sa nakaraang taon.

DSWD Uses Holistic Approach To Address Gender-Based Violence

DSWD patuloy na nagbibigay ng komprehensibong programa upang suportahan ang mga biktima at perpetrator ng karahasan batay sa kasarian.

China Approves CoronaVac Use For Kids 3-17 Years Old

China's CoronaVac, which has 98.9 percent effective in producing antibodies and a higher efficacy, can now be used for kids three to 17 years old, the Chinese Embassy in Manila reported.
By The Philippine Post

China Approves CoronaVac Use For Kids 3-17 Years Old

0
0

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

China has approved for emergency use the Sinovac-manufactured CoronaVac for children from three to 17 years old, the Chinese Embassy in Manila reported Tuesday.

In a statement, the Embassy said the approval is based on Phase III clinical trial data that suggest CoronaVac is “at least 98.9 percent effective in producing antibodies, a higher efficacy than in population over 18 years old.”

The Embassy said the study involved 180 volunteers within the age group.

The results showed the development of antibodies was 98.9 percent to 100 percent depending on the dosage after the administration of the second shot.

On its website, Sinovac said the amount of the neutralizing antibody was close to the level recorded 28 days after vaccination and remained significantly higher than the level recorded in adults and the elderly in the same period.

“This indicates that CoronaVac has stable and good immunogenicity among the children and adolescent population, recording better results compared to those in people aged 18 and above,” it said.

The Philippines granted an emergency use authorization (EUA) to Sinovac’s jab in February 2021 for healthy individuals aged 18 to 59.

On July 7, the Chinese firm applied for an amendment of their EUA to include children from three to 17 years old but as of this posting, no decision has been announced yet by the country’s Food and Drug Administration. (PNA)